Aveo Pharmaceuticals Inc $1.39

up +0.03


16/4/2014 08:10 PM  |  NASDAQ : AVEO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AVEO Trend Analysis - it has underperformed the S&P 500 by 99%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Stocks Hitting 52-Week Lows

    Benzinga
  3. Earnings Scheduled For March 13, 2014

    Benzinga
  4. Benzinga Weekly Preview: Ukraine Tension Likely To Drive Markets

    Benzinga
  5. Stocks Hitting 52-Week Lows

    Benzinga
  6. Stocks Hitting 52-Week Lows

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. US Stock Futures Gain Ahead Of Producer Price Index

    Benzinga
  9. AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary ...

    Benzinga
  10. Wild Card Wonders, Shopping for 52-Week Lows

    GuruFocus
  11. Sure Hope You Ignored This Dude on Aveo Stock

    YCharts
  12. Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low

    GuruFocus
  13. Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming

    GuruFocus
  14. 13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options

    Benzinga
  15. A Peek Into The Market Before The Trading Starts

    Benzinga
  16. AVEO, Astellas Announce Presentations of Tivozanib Clinical Data

    Benzinga
  17. AVEO Pharmaceuticals Closes Public Offering

    Benzinga
  18. Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA

    GuruFocus
  19. AVEO Pharmaceuticals, Inc. (AVEO) CEO Ngoc Tuan Ha buys 75,000 Shares

    GuruFocus
  20. A Peek Into The Market Before The Trading Starts

    Benzinga
  21. AVEO, Astellas Announce FDA Acceptance of NDA Filing for Tivozanib

    Benzinga
  22. UPDATE: Stifel Nicolaus Initiates AVEO Pharmaceuticals at Sell; Tivozanib ...

    Benzinga
  23. UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Aveo Pharmaceuticals

    Benzinga
  24. AVEO Oncology Announces Strategic Restructuring

    Benzinga
  25. AVEO and Astellas Announce Submission of New Drug Application for Tivozanib

    Benzinga
  26. New Clinical Data on AVEO Oncology's Tivozanib and Ficlatuzumab to be Presented ...

    Benzinga
  27. Health Care Sector Wrap

    FoxBusiness
  28. Health Care Sector Wrap

    FoxBusiness
  29. NxStage Medical, Assisted Living Concepts Among Stocks setting 52-Week ...

    FoxBusiness
  30. AVEO Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  31. Health Care Sector Wrap

    FoxBusiness
  32. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily Large ...

    FoxBusiness
  33. UPDATE: Jefferies Downgrades Aveo Pharmaceuticals to Hold on Regulatory ...

    Benzinga
  34. AVEO Pharmaceuticals Inc. (AVEO) CFO David Brannon Johnston sells 15,0 ...

    GuruFocus
  35. AVEO and Astellas Announce TAURUS Patient Preference Clinical Study Comparing ...

    Benzinga
  36. AVEO Pharmaceuticals Inc. (AVEO) President & CEO Ngoc Tuan Ha sells 4,613 ...

    GuruFocus
  37. AVEO Pharmaceuticals Inc. (AVEO) CFO David Brannon Johnston sells 1,107 ...

    GuruFocus
  38. End-of-Day Market Summary for January 3, 2012

    Benzinga
Trading Center